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There has been an increasing appreciation of the role of vascular contributions to cognitive 28 
impairment and dementia (VCID) associated with old age. Strong preclinical and translational 29 
evidence links age-related dysfunction and structural alterations of the cerebral arteries, 30 
arterioles and capillaries to the pathogenesis of many types of dementia in the elderly, 31 
including Alzheimer’s disease. The low pressure, low velocity and large volume venous 32 
circulation of the brain also plays critical roles in the maintenance of homeostasis in the 33 
central nervous system. Despite its physiological importance the role of age-relate alterations 34 
of the brain venous circulation in the pathogenesis of vascular cognitive impairment and 35 
dementia is much less understood. This overview discusses the role of cerebral veins in the 36 
pathogenesis of VCID. Pathophysiological consequences of age-related dysregulation of the 37 
cerebral venous circulation are explored, including blood brain barrier disruption, 38 
neuroinflammation, exacerbation of neurodegeneration, development of cerebral 39 
microhemorrhages of venous origin, altered production of cerebrospinal fluid, impiared 40 
function of the glymphatics system, dysregulation of cerebral blood flow and ischemic 41 
neuronal dysfunction and damage. Understanding the age-related functional and phenotypic 42 
alterations of the cerebral venous circulation is critical for developing new preventive, 43 
diagnostic, and therapeutic approaches to preserve brain health in older individuals.  44 
 45 
Key words: vascular contributions to cognitive impairment and dementia (VCID), VCI, 46 
senescence, vein, cerebral circulation    47 
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1. Introduction 48 
 Recent advances in cerebrovascular pathophysiology and vascular aging research 49 
highlight the significance of vascular contributions to cognitive impairment and dementia 50 
(VCID) associated with old age(79, 176, 189). VCID encompasses all types of vascular 51 
pathology-related cognitive decline, the most common being cerebral small vessel disease. 52 
Vascular cognitive impairment and dementia are now recognized as the second most common 53 
cause of cognitive decline in older individuals  often overlapping with Alzheimer’s disease. 54 
There is increasing recognition that vascular mechanisms contributing to cognitive 55 
impairment are potentially reversible and treatments and interventions that preserve 56 
cerebrovascular health may help to prevent cognitive decline, even of the Alzheimer type. The 57 
prevalence of vascular cognitive impairment and dementia is strongly age-related(63). 58 
Accordingly, there is ever growing evidence that age-related structural and functional 59 
alterations of large arteries, arterioles and capillaries lead to dysregulation of cerebral blood 60 
flow and ischemia, blood brain barrier disruption, impaired clearance of metabolic by-61 
products, increased neuroinflammation and impaired paracrine regulation of the function of 62 
neighboring cells (e.g. neuronal stem cells), all of which act synergistically to impair brain 63 
function. There is also strong evidence demonstrating the contribution of age-related 64 
alterations in arteriolar microvessels and capillaries to Alzheimer's disease(164, 176).  65 
 The low pressure, low velocity and large volume venous circulation of the brain plays 66 
critical roles in the maintenance of homeostasis in the central nervous system. Despite its 67 
physiological importance the role of age-relate alterations of the brain venous circulation in 68 
the  69 
pathogenesis of vascular cognitive impairment and dementia and Alzheimer's disease is much 70 
less understood. In this review, the effect of aging on the functional and structural integrity of 71 
the brain venous circulation is considered in terms of potential mechanisms involved in the 72 
pathogenesis of neurodegeneration and cognitive decline.  73 
 74 
2. Anatomy and physiology of cerebral venous circulation and cerebrospinal fluid 75 
dynamics 76 
The venous circulation of the brain consists of two main systems: the superficial 77 
(cortical) and the deep venous system (Figure 1). The superficial venous system drains the 78 
cortex and superficial white matter mainly collected by dural sinuses, the superior sagittal 79 
sinus and the cavernous sinus. In addition to direct contacts to sinuses, venous blood also 80 
reaches the sinuses through bridging veins between the superficial venous network and the 81 
superior saggital sinus running in the subdural space. The deep venous system, which consists 82 
of the internal cerebral veins, vein of Rosenthal and Galen and their collaterals, drains the 83 
deep white matter, the lateral ventricle, third ventricle and basal cistern via the straight sinus. 84 
Ultimately the venous blood of the superficial and deep system drains through the sigmoid 85 
sinus to the veins of the neck, most importantly to the jugular veins(105, 236). The 86 
intracerebral veins possess no valves, and their walls are extremely thin (and vulnerable) due 87 
to the absence of a well-developed smooth muscle layer(65, 105).  88 
The internal jugular veins are considered to be the main pathways of cerebral venous 89 
drainage. However, angiographic and anatomical evidence demonstrate that a wide 90 
anatomical variability exists that results in varying contributions of jugular and non-jugular 91 
venous drainage(64). Furthermore, there is significant postural dependency of the cerebral 92 
venous outflow(203). In the supine position there is a predominance of the jugular veins in 93 
cerebrovenous drainage. In contrast, in the erect position, the vertebral venous system 94 
represents a major outflow pathway(203). For example, the inner jugular vein diameter 95 
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increases and the distensibility decreases while reclining due to the intraluminal pressure 96 
elevation – forming most of the cerebral venous drainage in the majority of normal subjects 97 
(about 70%), called jugular drainers. In the remaining 30% of the normal population draining 98 
occurs via the vertebral veins, deep neck veins or via the intraspinal venous system. Reduced 99 
diameter and high distensibility of the inner jugular vein could be observed in the erect body 100 
position when the intraluminal venous pressure is low as blood flow to the atrium is facilitated 101 
by gravity and most of the cerebral venous drainage is ensured by the vertebral venous 102 
system(27, 64).   103 
 To understand brain pathologies of venous origin it is crucial to understand to 104 
crosstalk between cerebral blood flow (CBF) and cerebrospinal fluid (CSF) and thus so the 105 
interaction between the venous system and the CSF. According to the classical theory, CSF is 106 
produced by the choroid plexus and flows through the ventricles, cisterns and subarachnoid 107 
space to ultimately be absorbed into the venous blood by the arachnoid villi(19, 33). The 108 
pressure gradient needed for this absorption between the two spaces is 5-7 mmHg. Thus, any 109 
increase in the venous sinus pressure may significantly affect CSF absorption (22). In addition 110 
to the unidirectional flow of CSF from the site of production to the site of absorption, it also 111 
exhibits pulsatility(19, 212) as the fluid compartment of CSF serves as a Windkessel, 112 
dampening the arterial pulse wave entering the skull. Since the brain requires nonpulsatile and 113 
continuous flow, the Windkessel effect is a critical function of both the CSF and cerebral 114 
venous fluid compartments. The Monro-Kellie doctrine describes the principle of homeostatic 115 
intracerebral volume regulation, which stipulates that the total volume of the parenchyma, 116 
cerebrospinal fluid, and blood remains constant. Accordingly, since blood and CSF are not 117 
compressible the arterial pulsation results in CSF shift through foramen magnum or a 118 
compression of the veins. Thus any change in the venous circulation, namely pressure 119 
overload, backward flow, or even a change in the compliance of the neck and brain veins not 120 
just affects the drainage of the brain, but may also lead to alterations in CSF homeostasis(19).  121 
 122 
3. Structural and functional alterations affecting the cerebral venous circulation in aging 123 
  124 
3.1. Structural/morphological alterations and altered distensibility of cerebral veins in aging 125 
 Aging is known to alter the structure of cerebral capillaries, promoting structural 126 
abnormalities of the basement membrane, increasing perivascular collagen deposits, and 127 
leading to basement membrane thickening(69). Age-related increased collagenosis also occurs 128 
in cerebral veins and venules(34, 130), due to increased expression and deposition of collagen 129 
subtypes I and III in the vascular wall. This age-related remodeling of the venous wall is 130 
thought to maintain venous tensile strength in response to pathologic penetration of the 131 
increased arterial pulse wave (due to stiffening of large conduit arteries) through the capillary 132 
network into the venous system in aging(172). Venous collagenosis was reported to be 133 
increased in brains with manifest leukoaraiosis(34), suggesting that pathological remodeling 134 
of the venous wall may contribute to white matter lesions both in normal aging and in 135 
Alzheimer’s disease(104).  136 
 Arteriolar tortuosity is a frequent age-related vascular pathology in the white matter, 137 
that often associates with leukoaraiosis(34). Tortuous vessels are often surrounded by 138 
enlarged perivascular spaces corresponding to 'État criblé' (also known as status cribrosum) 139 
(34). Histopathological examination of postmortem brains of older individuals as well as 140 
advanced imaging modalities in vivo (e.g. ultra-high field time-of-flight MR angiography and 141 
susceptibility-weighted imaging [SWI]) reveal that venules also often exhibit age-related 142 
increased tortuosity(100, 148) (Figure 2A). Recent studies provide preliminary evidence that 143 
venular tortuosity may be an early neuroimaging marker of small vessel disease and may 144 
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correlate with white matter hyperintensities and/or cerebral microhemorrhages(148). A recent 145 
study comparing deep medullary veins visualized on 7T-MRI revealed that patients with early 146 
Alzheimer's disease also exhibit increased venular tortuosity(32). It should be noted that the 147 
existing imaging studies reporting venular tortuosity in aging and/or in Alzheimer's disease 148 
patients are cross-sectional in nature, thus its remains to be determined whether venular 149 
tortuosity is a progressive condition. 150 
 The mechanisms underlying increased venous tortuosity are multifaceted and, based 151 
on analog mechanisms manifested in the peripheral circulation, likely include increased 152 
cerebral venular pressure (similar to the hemodynamic environment promoting varicose vein 153 
formation in the lower extremities(112)), altered elasticity of the vascular wall, degenerative 154 
changes of the smooth muscle and endothelial cells and pathological remodeling of the 155 
extracellular matrix and basal membrane(100). Age-related mechanisms that promote adverse 156 
remodeling of the venular wall include impaired expression of angiogenic and growth factors 157 
(e.g. VEGF), cellular senescence, oxidative stress and dysregulation of MMPs(100). 158 
Interestingly, pharmacological depletion of mural cells using a platelet-derived growth factor 159 
receptor-beta antagonist was reported to increase venular tortuosity in animal models(111), 160 
mimicking the aging phenotype. It is likely that cerebral venous tortuosity correlates with the 161 
presence of retinal tortuous veins, due to shared etiology(83). In that regard it is interesting 162 
that increased tortuosity of retinal venules was shown to predict Alzheimer's disease(39).  The 163 
critical role for increased venous pressure in the genesis of venous tortuosity is supported by 164 
the findings that patients with venous congestion related to an intracranial dural arteriovenous 165 
fistula also exhibit tortuous, engorged pial veins clearly visible on angiograms(222). 166 
Examples of focal and diffuse tortuosity in cerebral veins due intracranial arteriovenous 167 
fistulas are shown in Figure 2B-D.  168 
 Age-related alterations of the bridging veins, which connect the superficial venous 169 
network to dural sinuses, play a central role in traumatic brain injury-related subdural 170 
bleedings in the elderly(84). Because of brain atrophy and subsequent expansion of the 171 
subdural space increased mechanical tension is imposed on the bridging veins in the 172 
elderly(84, 229). This increased mechanical burden combined with the age-related decline in 173 
elasticity of venous wall predispose the bridging veins to rupture in response to even minor 174 
brain trauma, resulting in increased incidence of bleedings into the subdural space in older 175 
adults(84, 229).  176 
The venous wall is significantly more distensible compared to the arterial wall, which 177 
has important physiological relevance.  The distensibility of the internal jugular vein is a 178 
major determinant of cerebral venous drainage and keeps cerebral venous pressure within 179 
normal values. There is strong evidence that aging reduces the distensibility of the upper limb 180 
venous system by 38% when determined by plethysmography(75). Aging also decreases 181 
jugular vein distensibility by 68% (measured by ultrasonography)  in the supine position 182 
(although this effect may have postural dependency(27)). It is likely that due to an age-related 183 
reduction in distensibility, the inner jugular vein loses its compensatory ability to increased 184 
transmural pressure and thereby predisposes the cerebral venous system to venous 185 
hypertension. It is likely that the effects of aging on the venous wall biomechanics are 186 
multifaceted and include age-related pathological remodelling of the venous wall, including 187 
changes in the extracellular matrix and the medial layer. Age-related changes of the 188 
biomechanical properties of jugular venous walls are also defined by aging-induced changes 189 
in venous tone, intra- and extraluminal pressure, and the relationship to surrounding tissues. 190 
The age-related changes in the multilevel control of venous biomechanics likely includes 191 
alterations in intrinsic local myogenic and humoral mechanisms as well as extrinsic systemic 192 
hormonal and nervous influences(129). Hemodynamic factors (changes in pressure and flow) 193 
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together with inflammatory processes contribute to the age-related changes in the 194 
biomechanical properties of the jugular veins, which further promote age-related progression 195 
of venous dysfunction(127). Several age-associated pathological conditions, including chronic 196 
heart failure, pulmonary hypertension and chronic obstructive pulmonary disease can elevate 197 
central venous pressure in the elderly and thereby alter biomechanical properties of the 198 
veins. In addition, sex, obesity and sedentary lifestyle may importantly modulate the effects of 199 
aging on biomechanical properties of the cerebral venous system(8, 9, 121), similar to 200 
peripheral veins(71, 119). Studies on 70 adult Caucasian twins from the Italian twin registry 201 
demonstrate that hereditary factors are responsible for 30-70% of the biomechanical 202 
properties of internal jugular veins(170). Longitudinal studies should elucidate how genetic 203 
factors determine successful venous aging and predispose to exacerbated pathological 204 
remodelling of the cerebral venous system in aging.     205 
 Numerous malformations can also affect the venous circulation of the neck in older 206 
subjects, leading to impaired venous drainage in the brain(236). Causes of narrowing or 207 
occlusion can be intraluminar, such as septa, flaps, abnormal valves or extraluminar such as 208 
any anatomical or pathological mass compressing the vessel.  209 
 Abnormal remodeling and increased stiffness of the venous wall and/or increases in 210 
venous pressure may impair the Windkessel effect of the venous circulation(19, 212). As the 211 
venous circulation plays a bigger role in the Windkessel effect and dampening of arterial 212 
pulsatility with aging, any age-related alteration that affects the venous system will exert a 213 
significant impact on penetration of the arterial pressure wave into the brain(19). Increased 214 
pulse pressure can reach the venous side through the arterial tree due to the lack of proper 215 
myogenic autoregulatory protection in the proximal cerebral resistance arteries(174, 176, 216 
178). In addition, increased arterial pulsation can be transmitted to venous pulsation indirectly 217 
through the CSF. In the presence of age-related alterations of CSF circulation, when 218 
compliance of the CSF compartment is decreased, less dampened pulse waves can reach the 219 
venules and veins. The age-related increased pulse pressure due to arterial stiffening and the 220 
lack of arterial myogenic protection together with the decreased Windkessel function of the 221 
CSF compartment imposes mechanical stress on the venous wall in aged individuals. There is 222 
also a cross talk between the different types of venous abnormalities as structural and 223 
morphological changes may lead to hemodynamic consequences. For example pressure 224 
elevation in the sagittal sinus will also increase pressure in the cortical veins making them 225 
more stiff and resistant against compression, compromising the Windkessel effect(19). 226 
  Previous preclinical studies have characterized age-related degenerative changes and 227 
pathological remodeling in venous valves(87), which likely contribute to venous valve 228 
insufficiency associated with old age. Clinical studies confirm that aging is associated with 229 
pathological remodeling of venous valves in the peripheral venous circulation, which likely 230 
impairs valve function(146, 205). Based on our understanding of the pathogenesis of chronic 231 
venous insufficiency in the peripheral circulation, it is likely that age-related changes in 232 
cerebral venous valves contribute to valvular incompetence(204), leading to venous reflux 233 
and cerebral venous hypertension. 234 
 235 
3.2. Jugular venous reflux and increased cerebral venous pressure 236 
 Increased cerebral venous pressure is likely to contribute to pathological processes that 237 
play a significant role in development of brain pathologies in older individuals, including 238 
microhemorrhages, blood-brain-barrier disruption and perivascular inflammation(125, 191). 239 
When venous hypertension occurs in the superior sagittal sinus, CSF absorption is also 240 
impaired, leading to altered CSF outflow. Factors that contribute to increased cerebral venous 241 
pressure include penetration of arterial hypertension to the venous circulation, venous 242 
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drainage impairment, presence of an arteriovenous fistula and retrograde transmission of 243 
increased central venous pressure to the cerebral venous circulation.   244 
 Jugular venous reflux is a clinically potentially important hemodynamic abnormality 245 
(Figure 3). It can be caused for example by physiologic compression of the brachiocephalic 246 
vein that leads to stagnation or reversal of the internal jugular vein flow, promoting increased 247 
cerebral venous pressure. The pressure gradient determines the flow in the veins and a 248 
missing or damaged internal jugular vein valve can easily lead to retrograde flow(45).  249 
 The internal jugular vein valve, which is the only venous valve situated in the venous 250 
circulation between the heart and the brain, is critical for the prevention of retrograde flow of 251 
venous blood. Despite their clinical significance, the presence and function of the valves in 252 
the internal jugular veins are often overlooked(62, 115). Anatomical evidence obtained in 253 
human cadavers suggest that internal jugular vein valve is frequently incompetent. With an 254 
incompetent internal jugular vein valve any increase in intrathoracic pressure (e.g. during 255 
Valsalva maneuver) could result in jugular venous reflux(236). The incidence of jugular 256 
venous reflux has been reported to increase with age(92, 96, 103, 106, 109, 184), likely due to 257 
age-related degenerative changes in the venous valves. Interestingly, there are studies extant 258 
reporting that incidence of jugular valve incompetence can reach ~30 to 90% in the general 259 
population(2, 204).  Jugular valve insufficiency and the resulting retrograde jugular venous 260 
flow and back transmission of central venous pressure likely contribute to various brain 261 
pathologies. Jugular venous reflux was shown to associate with intracranial structural changes 262 
in patients with mild cognitive impairment and Alzheimer's disease(21, 24). It has been 263 
suggested that jugular venous reflux retrogradely transmits increased venous pressure into the 264 
brain, promoting edema as well as a wide range of microvascular pathologies associated with 265 
increased venular pressure. There are case reports extant showing that age-related jugular 266 
valve incompetence in association with the physical exertion during sexual intercourse 267 
possibly can lead to intra-cerebral hemorrhage of venous origin(4).  268 
 There are case reports extant suggesting that during central venous catheter placement 269 
venous valves located in the right internal jugular vein may be damaged(72, 225). Because the 270 
internal jugular valve is often located in the retroclavicular space, the ultrasound assessment 271 
of this valve can be difficult. Valve cusps are thin structures and forceful attempts to force a 272 
catheter through them may result in valve damage. 273 
 274 
3.2. Age-related phenotypic and genotypic changes in endothelial cells   275 
 Despite their common developmental origins, endothelial cells in the arterial and 276 
venous circulatory system are not identical(61). Functionally, one of the key roles of arteriolar 277 
endothelial cells is the regulation of vascular tone and thereby blood flow and the production 278 
of a number of trophic factors, paracrine mediators and gaseotransmitters. On the other hand 279 
post-capillary venular endothelial cells are the primary site of leukocyte trafficking and stem 280 
cell extravasation. Interestingly, recent studies report that cerebral arteries and veins 281 
differentially exhibit an endothelial glycocalyx (e.g. in mice cerebral arteries and capillaries 282 
have an intact endothelial glycocalyx, but veins and venules do not(231)), which may have 283 
relevance for regulation of inflammatory processes. Among the endothelial glycocalyx 284 
constituents, syndecan-1 is a main component and it is also predominantly expressed in 285 
arterial endothelial cells as compared to venous endothelial cells in the brain(86). Despite the 286 
pathophysiological importance of the venous endothelium, the role of age-related functional 287 
changes in the venous endothelial cells have not been explored.  288 
 There is ample evidence that aging is associated with critical phenotypic alterations in 289 
the endothelial cells in the arterial circulation due to age-related changes in their gene 290 
expression profile(16, 52, 56, 58, 167, 183, 188, 192, 193, 197). Studies on endothelial cells 291 
from diverse vascular beds suggest that aging promotes pro-inflammatory, pro-oxidative and 292 
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pro-senescence changes in endothelial gene expression in the arterial circulation altering the 293 
cytokine and chemokine secretory profile of endothelial cells(51, 57, 58, 73), dysregulating 294 
mitochondrial biogenesis(197), altering transport, barrier and vasomotor function and free 295 
radical production(56, 167, 178, 182), impairing angiogenic capacity(16, 51, 192, 193) and 296 
facilitating endothelial-leukocyte interactions(51, 53, 185, 198).  It can be hypothesized that if 297 
aging is associated with gene expression changes in endothelial cells in the venous circulation 298 
which are similar to those in endothelial cells in the arterial circulation then these changes 299 
may significantly contribute to pathological processes promoting neuroinflammation and 300 
impaired tissue homeostasis. Venous endothelial cells express unique molecular markers(86), 301 
including Endomucin (Emcn)(232), Ephrin type-B receptor 4 (EphB4), Lefty-1, Lefty-2, 302 
Neuropilin-2, and Flt4(61). Preliminary analysis did not reveal significant age-related changes 303 
in the gene expression profile of these markers in the mouse brain. Further studies are 304 
warranted to isolate endothelial cells from the venous circulation based on these surface 305 
markers and analyze age-related changes in functionally relevant genes (e.g. inflammation-306 
related gene expression, including adhesion molecules and chemokines). A recent 307 
breakthrough study published a single-cell RNA sequencing dataset that defines arterial, 308 
capillary and venous endothelial cells in mouse brain(86). This study identified >180 genes 309 
that are enriched (over 2 fold) in venous endothelial cells versus capillary endothelial cells 310 
(including Gm5127, Wnt5a, Ptgs2, Cfb, Cfh). Interestingly, among them Vcam1 and Icam1 311 
shows a ~54 fold and ~4 fold enrichment, respectively, in venous endothelial cells versus 312 
capillary endothelial cells, which corresponds to the primary role of the post-capillary venules 313 
in leukocyte transmigration. Using single-cell RNA sequencing future studies should compare 314 
age-related changes in these subsets of endothelial cells.   315 
 316 
4. Potential role of pathological alterations of the cerebral venous circulation in 317 
neurodegenerative diseases and cognitive decline 318 
 The links among alterations in the cerebral venous circulation, neurogenerative 319 
diseases and cognitive impairment are not well understood. Here we provide a review of 320 
existing data supporting a potentially important role for venous dysfunction in different brain 321 
pathological conditions. Some speculations are also offered as to the mechanisms by which 322 
alterations of the cerebral venous circulation may contribute to the pathogenesis of age-related 323 
cerebral diseases and cognitive decline.    324 
 325 
4.1. Chronic cerebrospinal venous insufficiency: lessons from studies on multiple sclerosis  326 
 Originally Zamboni et al proposed the hypothesis that cerebrospinal venous 327 
insufficiency, caused by intraluminal stenotic malformations in the internal jugular and 328 
azygos veins with insufficient opening of collaterals. leads to impaired venous drainage of the 329 
brain and thereby contributes to the pathogenesis of multiple sclerosis (MS) (234). This 330 
hypothesis was built on the findings of early studies that MS lesions have venous 331 
involvement(59, 139, 140). According to Zamboni's hypothesis, cerebrospinal venous 332 
insufficiency is similar to chronic venous disorders of the lower extremity in that the altered 333 
hemodynamic environment in the venous circulation promotes chronic inflammation, iron 334 
deposition and tissue injury(233). In support of this hypothesis Zamboni and co-workers 335 
reported that in MS patients there are alterations in venous drainage of the brain(234). 336 
However, these results proved to be controversial due to the lack of scientific rigor (e.g. 337 
proper controls)(135) and could not be reproduced by other investigators(47, 142, 180), 338 
mainly due to the high degree of variability and non-specificity of the diagnostic ultrasound 339 
criteria (reflux, internal jugular vein stenosis, absent flow detectable by Doppler 340 
ultrasonography in the internal jugular or vertebral veins, reversed postural flow in the 341 
internal jugular vein) that define cerebrospinal venous insufficiency. Other investigators 342 
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proposed that pulse wave encephalopathy may be an initiating step in the pathogenesis of 343 
MS(101). In support of this hypothesis increases in the Virchow-Robin space, decreased 344 
intracranial compliance and higher microvascular pulsatility have been reported in MS 345 
patients(101). Given the critical role of the venous circulation in inflammatory processes (e.g. 346 
endothelium-leukocyte interactions), control of the blood brain barrier, microglia activation 347 
and microvascular injury, further studies are warranted to better elucidate the role of 348 
hemodynamic factors in general and the venous pathologies in particular in the pathogenesis 349 
of various forms of neurodegenerative diseases.  350 
 351 
4.2 Leukoaraiosis/white matter hyperintensities 352 
 Leukoaraiosis is a radiological finding showing damage in the white matter regions of 353 
the brain near the lateral ventricles on CT scans (showing up as hypodense periventricular 354 
white-matter lesions) or on T2/FLAIR MRI sequences (white matter hyperintensities or 355 
WMHs; Figure 4A). Its clinical significance stems from the association of leukoaraiosis with 356 
vascular dementia, gait disturbances and stroke(133). WMHs have been detected in patients 357 
with Alzheimer's disease(94, 102, 124) or at risk for developing Alzheimer's disease(46). The 358 
current view is that WMHs are early and independent predictors of Alzheimer's disease(131). 359 
WMH burden is even more significant in patients with vascular cognitive impairment (6, 30). 360 
There are numerous studies attempting to define the neuropathological correlates of WMHs 361 
(reviewed recently in reference(100)), which include a variety of small vessel pathologies 362 
(accentuation of perivascular Virchow-Robin spaces, sclerotic vessels, microvascular 363 
amyloidosis, arteriolosclerosis, hyalinosis and collagenosis), gliosis, periventricular necrosis 364 
and axonal degeneration and reactive astrocytosis. Global WMHs are hypoperfused compared 365 
with normal white matter, suggesting that ischemia may play a role in their pathogenesis 366 
(124).   367 
 Important for the present overview is the observation that leukoaraiosis is associated 368 
with a number of venous abnormalities, including periventricular venous collagenosis(130) 369 
and venular tortuosity. Jugular venous reflux and increased cerebral venous pressure were 370 
suggested to contribute to the pathogenesis of leukoaraisosis (44). Chronic cerebral venous 371 
hypertension likely decreases cerebral blood flow promoting local ischemia in the white 372 
matter(44), disrupts the blood brain barrier promoting perivascular inflammation and 373 
exacerbates pathological remodeling of the cerebral venules. Progressive injury of the 374 
ischemic periventricular white matter is likely exacerbated by damage to the blood-brain 375 
barrier, accumulation of toxic metabolites and pro-inflammatory plasma constituents, the 376 
heightened inflammatory status of microglia and astrocytes and/or by the presence of amyloid 377 
deposits(102). Higher venous pressure, remodeling of the veins and/or jugular venous reflux 378 
may lead to impaired Windkessel effect and increased pulsatility in the capillary bed. Higher 379 
pulsatility per se may contribute to the pathogenesis of leukoaraiosis(18).  380 
 381 
4.3 Normal pressure hydrocephalus (NPH) 382 
 NPH results from an abnormal accumulation of CSF in the ventricles of the brain, 383 
leading to ventriculomegaly(67). The enlarged ventricles exert increased pressure on the 384 
adjacent cortical tissue, impairing brain function and resulting in gait disturbance, dementia, 385 
and urinary incontinence(67). NPH patients are known to have an accumulation of CSF and 386 
dilation of the ventricles without an intracranial pressure elevation, which is canonically 387 
explained by lower absorption of CSF by the arachnoid villi to the venous circulation(152). 388 
An alternative hypothesis focuses on the decreased venous compliance in NPH patients(17). 389 
In NPH patients intracranial venous flow and pressure are abnormal(110) and it is believed 390 
that an elevation of venous pressure contributes significantly to the neuronal damage and 391 
dysfunction associated with NPH(17). Venous hypertension may not only promote pulse 392 
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wave encephalopathy but also impair reabsorption of CSF through the arachnoid villi leading 393 
to abnormal accumulation of CSF(152). Interestingly, there is a higher prevalence of 394 
cardiovascular diseases in patients with NPH, suggesting that the pathogenesis of NPH and 395 
cardiovascular disease may be linked(66), for example by increasing jugular venous pressure.  396 
 397 
4.4 Role of the venous circulation in the pathogenesis of cerebral microhemorrhages 398 
 Cerebral microhemorrhages (CMHs, also known as “cerebral microbleeds”)(191), 399 
which are associated with rupture of small intracerebral vessels, are highly prevalent in 400 
patients 65 and older(191). CMHs have been defined as multiple small (<5 to 10 mm in 401 
diameter)  round or oval hypointense lesions on T2*-weighted Gradient-Recall Echo (T2*-402 
GRE) MRI sequences, which correspond to focal, persisting hemosiderin depositions in 403 
microglia. There is strong evidence from population-based cross-sectional studies that CMHs 404 
contribute significantly to cognitive decline(37, 89, 138, 191, 206, 219, 220, 224, 227, 228). 405 
Although many CMHs likely originate from small arterioles (they main risk factors 406 
being aging, hypertension and amyloid deposition), there is increasing evidence that rupture 407 
of small veins and venules as well as capillaries can also result in CMHs(161, 191). In support 408 
if this concept recent evidence shows that development of CMHs can be causally linked to the 409 
performance of Valsalva maneuvers(195). The Valsalva maneuver (defined as a forced 410 
expiratory blow against a closed glottis) is common in many everyday activities that involve 411 
moderate exertion, including weight lifting, blowing air into inflatable devices or musical 412 
instruments (e.g. playing the oboe), intense coughing, vomiting, nose blowing and strain 413 
during defecation or sexual intercourse(195). Intrathoracic pressure in these conditions may 414 
increase well over >150-200 mmHg(149), which is transmitted to the venous circulation, 415 
resulting in a substantial elevation in central venous pressure(226). If in older individuals the 416 
internal jugular vein valves are incompetent, they would enable retrograde transmission of 417 
increased venous pressure to the cerebral venous system during the Valsalva maneuver(42, 418 
70, 235, 236). It is likely that when in elderly patients venous pressure exceeds the threshold 419 
for structural injury in thin-walled cerebral venules, multifocal venous CMHs ensue. In 420 
support of this concept, there is direct evidence that retinal hemorrhages of venous origin can 421 
be also generated by Valsalva maneuvers(3, 38). Preclinical studies on mouse models with 422 
surgical jugular vein occlusion(14) confirm that elevation of venous pressure in the cerebral 423 
circulation promotes the development of CMHs (Fulop and Ungvari, 2018, unpublished 424 
observation). Further, when retrograde penetration of a venous pressure wave into the cerebral 425 
venous circulation is mimicked experimentally by injecting a carmine-gelatine solution under 426 
high pressure into the vein of Galen in human cadavers, multifocal venous ruptures develop. 427 
These studies suggest that pressure-induced venous ruptures are predominantly localized to 428 
the region of lateral ventricle, where there are connections between medullary and 429 
subependymal veins(147). It is likely that these vessels are more prone to rupture due to their 430 
branching pattern, anatomy as well as the structural characteristics of their walls.    431 
Another line of evidence supporting an important role of venous aging in the 432 
pathogenesis of intracerebral hemorrhages comes from studies on arteriovenous 433 
malformations (AVM)(134). AVMs are congenital vascular lesions  (incidence: ~ 1 per 434 
100,000 persons). The risk for AVM rupture significantly increases with age(50, 107), 435 
suggesting that with advanced aging the fragility of the venous wall increases. We posit that 436 
age-related structural changes in the venular wall also promote venular fragility, contributing 437 
to the pathogenesis of CMHs of venous origin in older individuals.  438 
 439 
4.5. Role of the venous circulation in the pathogenesis of cerebral microinfarcts 440 
Cerebral microinfarcts are small (0.05–3 mm in diameter) ischemic lesions that are 441 
prevalent in the aged human brain(10, 11, 35, 85). The association between the number of 442 
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cerebral microinfarcts and cognitive decline has been established by population-based 443 
radiological and pathological studies and confirmed by histopathological examinations(77, 444 
154, 155, 209, 210). Current thinking suggests that cerebral microinfarcts develop due to 445 
critical ischemia induced by the occlusion of arteriolar microvessels, which supply the 446 
respective small volume of brain tissue. Recent experimental studies demonstrated the 447 
occlusion of small venules can also lead to the genesis of cerebral microinfarcts, which appear 448 
identical to those resulting from arteriole occlusion(85). On the basis of these observations it 449 
has been proposed that cerebral venule pathology may also contribute to the pathogenesis of 450 
cerebral microinfarcts in older adults(85). Future clinical and experimental studies are 451 
warranted to establish the association between microinfarcts and venular pathology.  452 
 453 
4.6. Glymphatic circulation 454 
 The brain parenchyma does not contain lymphatic vessels. Instead, in the central 455 
nervous system the 'glymphatic' system (paravascular system) functions as a waste clearance 456 
pathway(98). The glymphatic system consists of a para-arterial influx route for cerebrospinal 457 
fluid to enter the brain parenchyma through the Virchow-Robin space and a para-venous 458 
efflux route. The inner wall of the perivascular space containing the flowing paravascular 459 
fluid is the outer wall of the vessels, and the outer wall of perivascular space is covered by 460 
astrocytic endfeet. According to the currently accepted hypothesis circulation of the 461 
cerebrospinal fluid in the paravascular system and the exchange of solutes between 462 
cerebrospinal fluid and interstitial fluid is driven primarily by arterial pulsation(29). Clearance 463 
of soluble proteins and metabolic by-products from the brain parenchyma is accomplished 464 
through convective bulk flow of interstitial fluid, facilitated by aquaporin 4 channels located 465 
on the astrocytic end-feet(26) (although there are important theoretical and experimental 466 
studies extant questioning the exact role of these mechanisms(99, 153)). There is 467 
experimental evidence that amyloid beta injected directly to the brain parenchyma is cleared 468 
through the glymphatic system along the large veins(91). It is believed that the glymphatic 469 
system drains into lymphatic vessels in the meninges (123).  It can be speculated that altered 470 
cerebral venous circulation may affect this clearance mechanism indirectly in older 471 
individuals. Since the interstitial fluid – cerebrospinal fluid mixture is partly collected through 472 
the arachnoid villi, the elevated venous pressure could adversely impact its reabsorption. 473 
  474 
4.7 Cognitive dysfunction in heart failure 475 
 Chronic heart failure  is a significant health problem in the Western world that affects 476 
≥ 10% of persons 70 years of age or older(116). Cognitive impairment is an important 477 
complication of heart failure among elderly people(20, 90, 223), with an incidence ranging 478 
from 25% to 80%)(116). Heart failure exerts multifaceted effects on the cerebral 479 
circulation(97). On the one hand, it attenuates cerebral blood flow by decreasing cardiac 480 
output (forward failure)(41, 48, 82, 122, 145), lowering blood pressure and impairing 481 
cerebrovascular reactivity, all of which have direct negative effects on brain function. 482 
Cerebrovascular autoregulation, which maintains cerebral blood flow constant despite 483 
changes in blood pressure in healthy subjects, is abnormal in heart failure patients, 484 
predisposing these patients to ischemic neuronal injury(36, 76). On the other hand, heart 485 
failure also causes systemic venous congestion (backward failure), which associates with 486 
increased jugular venous pressure and possibly reflux(218). There is evidence suggesting that 487 
heart failure patients exhibit WMHs(5), supporting the hypothesis that increased cerebral 488 
venous pressure is causally linked to the pathogenesis of leukoaraiosis (Figure 4A and B). 489 
Backward failure also likely leads to higher capillary pulsatility and decreased waste 490 
clearance through the perivascular glymphatic system.  491 
 492 
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5. Perspectives 493 
 Although in the past two decades significant progress has been achieved in 494 
understanding age-related alterations in vascular function and phenotype in the arterial 495 
circulation, research efforts should persist in this direction to investigate similar alterations in 496 
the venous circulation.  New investigations are needed to elucidate the mechanism by which 497 
age-related alterations in the venous circulation may lead to blood brain barrier disruption, 498 
neuroinflammation, dysregulation of CBF and local ischemia, promoting white matter injury 499 
and exacerbating VCI. Understanding the interaction of processes of aging and chronic 500 
diseases (e.g. hypertension, metabolic diseases) in the context of venous pathologies 501 
contributing to VCI should be a high priority. Studies on the venous circulation in both animal 502 
models of aging and accelerated vascular aging are warranted(162, 164). In addition, animal 503 
models to study the pathophysiological roles of increased cerebral venous pressure are 504 
needed. Potentially useful models include the mouse model proposed by Auletta et al., which 505 
involves surgical occlusion of the jugular veins in mice (14). The authors have characterized 506 
the model, which can be adapted to study consequences of cerebral venous hypertension as 507 
they relate to BBB disruption, dysregulation of CBF, white matter hyperintensities, 508 
pathogenesis of cerebral microhemorrhages of venous origin, cognitive impairment and gait 509 
disturbances. Further, better alignment of preclinical studies on venous aging and human 510 
investigations is needed.  511 
 Critical areas of research, based on recent achievements in the biology of aging, 512 
should focus on the role of known cellular and molecular mechanisms of aging in 513 
pathological alterations of the venous circulation.  New studies investigating role of 514 
sterile(221) and pathogen-induced vascular inflammation in the venous circulation are 515 
warranted. Importantly,  in the United States over 90% of adults 80 years of age or older have 516 
persistent human cytomegalovirus (CMV) infection(1, 93, 114, 132, 157, 160). CMV 517 
replicates in the vascular endothelial cells, including venous endothelial cells, during the 518 
entire life of the host following initial infection. Severity of CMV infection (assessed on the 519 
basis of circulating antibody titers) was shown to predict increased incidence of frailty and 520 
risk of mortality in older adults(214). There is also evidence linking CMV infection to sinus 521 
vein thrombosis(150). Additional studies invetsigating the pathogenic role of CMV-induced 522 
alterations in venous endothelial cells as they relate to heightened inflammatory status, 523 
structural remodeling, microhemorrhages and Alzheimer's pathology are needed. Additional 524 
important areas of research should focus on age-related changes in extracellular matrix(126, 525 
187, 194, 200), oxidative stress(56, 60, 108, 167, 187), mechanisms involved in altered 526 
cellular stress resilience(108, 166, 185, 186, 196, 202), pathways involved in cellular 527 
senescence(40, 136, 144, 177, 190, 213, 230), the pathogenic role of the renin-angiotensin 528 
system(55, 159, 181, 215-217), altered nutrient sensing pathways(7, 113, 173, 201), 529 
epigenetic factors(80, 199) and neuroendocrine mechanisms of aging(12, 13, 25, 68, 137, 141, 530 
171, 211), including IGF-1 deficiency(15, 74, 156, 163, 165, 168, 175, 179). Recent 531 
studies(118, 158) identified mTOR as a critical factor contributing to cerebral vascular 532 
damage and dysfunction in Alzheimer’s disease models(117, 118, 207, 208) and in models of 533 
VCI(95). It has to be determined how the pharmacological targeting of this pathway may 534 
affect the cerebral venous circulation. Innovative strategies need to be developed to improve 535 
the health of the venous circulation, including novel pharmacological strategies(28, 53, 54, 536 
118, 143, 158, 167) and modification of lifestyle and dietary factors(78, 81, 88, 128, 211).  537 
 To better understand the relationships between functional alterations of venous 538 
circulation, prospective clinical studies, similar to the Heart-Brain Study in the 539 
Netherlands(90), are needed. The Heart-Brain Study investigates the link between the 540 
hemodynamic status of the heart and the brain, and cognitive impairment in heart failure 541 
patients. Specifically, the Heart-Brain Study hypothesizes that the impaired hemodynamic 542 
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status of the heart and the consequential brain hypoperfusion are important determinants of 543 
VCI. Because backward failure and alterations of the venous circulation likely affect the 544 
brain, if would be advantageous to also include in the study design endpoints that reflect 545 
jugular venous reflux and cerebral venous pressure/microvascular damage. Using additional 546 
sensitive assays to detect markers of neuroinflammation(151) and behavioral 547 
consequences(23, 31, 120, 169, 211) would benefit both clinical and preclinical studies as 548 
well.  549 
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Figure legends 1259 
 1260 
Figure 1. Venous drainage of the central nervous system. Panel A: Venous phase cerebral 1261 
angiogram showing most of the cerebral venous structures. Image is taken from Coutinho et 1262 
al.  (49). Panel B: Normal anatomy of the cerebral venous system   1263 
 1264 
Figure 2. Cerebral venous tortuosity – a potential radiological sign of increased venous 1265 
pressure. Panel A) Detection of tortuosity in small intracerebral venules on susceptibility-1266 
weighted image (SWI; the MRI image was taken without the use of any contrast agents at 1267 
7T). "b" indicates a tortuous venule, whereas "c" marks a straight venule. "a" is an example of 1268 
a venule that would not be included in the statistical evaluation of venous tortuosity because it 1269 
was traced by only 1 of the 3 raters. Image is taken from reference(148). B-D) Examples of 1270 
focal (B) and diffuse (C) tortuosity in cortical veins on lateral views of the venous phase of 1271 
cerebral angiograms in patients with venous congestion related to intracranial arteriovenous 1272 
fistulas. Panel D: Frontal projection from cerebral angiogram showing venous tortuosity due 1273 
to a dural arteriovenous fistula. Images were kindly provided by Dr. Ali Shaibani (Department 1274 
of Neuroradiology, Northwestern University).     1275 
 1276 
Figure 3. Pathophysiology of jugular venous reflux. Panel A: Retrograde flow detected by 1277 
color duplex and in the Doppler spectrum during Valsalva maneuver (VM) reveals jugular 1278 
venous reflux in an older individual (mean age of study participants: 74±12 years). Image was 1279 
taken from reference(43). Panel B: Scheme depicting the role of jugular venous reflux in 1280 
transmission of increased central venous pressure to the cerebral veins and its consequences in 1281 
older adults. Jugular venous reflux occurs when increased intrathoracic pressure elevates 1282 
central venous pressure and the resulting venous pressure wave is beyond the competence of 1283 
internal jugular venous valves. Valsalva maneuver-induced jugular venous reflux may 1284 
retrogradely transmit venous hypertension into cerebral venous system, decreasing cerebral 1285 
perfusion pressure and consequently reducing cerebral blood flow and causing damage to the 1286 
thin-walled venules, including cerebral microhemorrhages of venous origin and blood-brain 1287 
barrier disruption.  1288 
Figure 4. Potential contribution of elevated venous pressure to increased incidence of 1289 
white matter hyperintensities in elderly heart failure patients. In older adults heart failure 1290 
was shown to associate with WMHs. Panel A: To illustrate this point this MRI scan shows 1291 
extensive periventricular WMHs on FLAIR sequences in a 64-year-old man with heart failure 1292 
associated with mild cognitive impairment (FLAIR: fluid-attenuated inversion recovery). 1293 
Panel B: Scheme depicting putative synergistic effects of heart failure-induced chronic 1294 
hypoperfusion of the brain and increased venous pressure, which may exacerbate white matter 1295 
injury promoting cognitive impairment in elderly patients with heart failure. RAAS: renin-1296 
angiotensin-aldosterone system 1297 
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